US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Latest News about SGLT2

Recent news which mentions SGLT2

2023 HFSA CME Symposium - Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure: From Evidence to Clinical Practice
Tags Education #HFSA2023 Hazlet
From PRLog
2023 ANNA CE Symposium- Newer Therapies to Optimize Outcomes in Patients with Chronic Kidney Disease
Tags Hazlet SGLT2 Event
From PRLog
CME Symposium- Bridging the Gap Between Evidence and Clinical Practice: Improving Outcomes with #SGLT2Inhibitors in Patients with #HeartFailure
Tickers CME
Tags Cardiovascular HFSA Medical
From PRLog